Dabigatran: all 149 studies that test it

Page 1 of 2. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With CirrhosisNot yet recruitingNCT06818279Phase 2/3
• Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus BacteremiaRecruitingNCT06650501Phase 4
• Dabigatran Versus Rivaroxaban in Cerebral Venous ThrombosisRecruitingNCT06551402Phase 3
• Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting ConditionsNot yet recruitingNCT06441916Phase 1
• THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingNCT05735639Phase 4
• MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke PreventionRecruitingNCT03961334Phase 3
• Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and CamlipixantCompletedNCT05959447Phase 1Results posted
• A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy AdultsCompletedNCT05673889Phase 1Results posted
• PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy ParticipantsCompletedNCT05064800Phase 1Results posted
• A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy ParticipantsCompletedNCT04782076Phase 1Results posted
• A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy ParticipantsCompletedNCT04459585Early Phase 1Results posted
• A Study in Healthy Men to Test the Influence of BI 1323495 on the Amount of the Medicines Rosuvastatin and Dabigatran in the BloodCompletedNCT04257032Phase 1Results posted
• Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).CompletedNCT03539055Phase 4Results posted
• Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in JapanCompletedNCT03143166Phase 1Results posted
• Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady StateCompletedNCT03086356Phase 1Results posted
• Bioequivalence of Tablet Formulation of Dabigatran Etexilate Compared to Commercial Capsule Formulation Following Oral Administration in Healthy Male SubjectsCompletedNCT03070171Phase 1Results posted
• Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial FibrillationCompletedNCT03061006Phase 4Results posted
• A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)CompletedNCT02913326Phase 3Results posted
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in CancerCompletedNCT02744092Not applicableResults posted
• Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)CompletedNCT02348723Phase 4Results posted
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)CompletedNCT02239120Phase 3Results posted
• Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of AgeCompletedNCT02223260Phase 2Results posted
• Safety of Dabigatran Etexilate in Blood Clot Prevention in ChildrenCompletedNCT02197416Phase 3Results posted
• Bioavailability of Different Applications of Dabigatran in Healthy VolunteersCompletedNCT02171611Phase 1Results posted
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)CompletedNCT02164864Phase 3Results posted
• Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy VolunteersCompletedNCT02044367Phase 1Results posted
• Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy SubjectsCompletedNCT02028780Phase 1Results posted
• Use of Dabigatran Etexilate to Prevent Stroke and ThromboembolismCompletedNCT01976507Phase 4Results posted
• Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal FunctionCompletedNCT01896297Phase 4Results posted
• Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)CompletedNCT01895777Phase 3Results posted
• Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation PostoperativelyTerminatedNCT01868243Phase 2/3Results posted
• Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet TherapyCompletedNCT01852162Not applicableResults posted
• Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.CompletedNCT01711853Phase 1Results posted
• Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran EtexilateCompletedNCT01688830Phase 1Results posted
• Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial FibrillationTerminatedNCT01546883Phase 4Results posted
• A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial FibrillationCompletedNCT01493557Phase 4Results posted
• Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy SubjectsCompletedNCT01306162Phase 1Results posted
• Bioequivalence of Two Different Capsule Types of DabigatranCompletedNCT01290757Phase 1Results posted
• Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During HaemodialysisCompletedNCT01241539Phase 1Results posted
• PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to WarfarinCompletedNCT01227629Phase 2Results posted
• BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement SurgeryCompletedNCT01225822Phase 2Results posted
• Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran EtexilateCompletedNCT01184989Phase 4Results posted
• A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to WarfarinCompletedNCT01136408Phase 2Results posted
• Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of AgeCompletedNCT01083732Phase 2Results posted
• Safety and Tolerability of Dabigatran Etexilate in AdolescentsCompletedNCT00844415Phase 2Results posted
• Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary InterventionCompletedNCT00818753Phase 2Results posted
• Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)CompletedNCT00680186Phase 3Results posted
• Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip ArthroplastyCompletedNCT00657150Phase 3Results posted
• RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary SyndromeCompletedNCT00621855Phase 2Results posted
• Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTECompletedNCT00558259Phase 3Results posted
• Secondary Prevention of Venous Thrombo Embolism (VTE).CompletedNCT00329238Phase 3Results posted
• Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous ThromboembolismCompletedNCT00291330Phase 3Results posted
• A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.CompletedNCT00246025Phase 2Results posted
• Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement SurgeryCompletedNCT00168818Phase 3Results posted
• RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee SurgeryCompletedNCT00168805Phase 3Results posted
• Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048TerminatedNCT00157248Phase 2Results posted
• A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female ParticipantsCompletedNCT07190430Phase 1
• Bioequivalence Study of Two Dabigatran Etexilate Mesylate Capsules in Healthy SubjectsCompletedNCT06876623Phase 1
• Dabigatran Versus Apixaban in Cerebral Venous ThrombosisStatus unknownNCT06551415Phase 3
• The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)Active, not recruitingNCT06449469Not applicable
• A Study to Learn About How BAY2927088 Affects the Level of Dabigatran or Rosuvastatin in the Blood When These Drugs Are Taken Together in Healthy ParticipantsCompletedNCT06329895Phase 1
• A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment PatientsStatus unknownNCT05747768Phase 4
• Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly SubjectsStatus unknownNCT05715658Not applicable
• Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants SubjectsStatus unknownNCT05491460Phase 1
• A Study to Learn How the Study Drug Elinzanetant (BAY 3427080) Affects the Way the Drug Dabigatran Moves Into, Through and Out of the Body in Healthy Male and Female ParticipantsCompletedNCT05471817Phase 1
• Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female VolunteersCompletedNCT05438303Phase 1
• Fruquintinib DDI Study With P-gp and BCRP SubstratesCompletedNCT05368805Phase 1
• Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCIStatus unknownNCT04688723Phase 4
• Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy SubjectsCompletedNCT04498741Phase 1
• Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein ThrombosisStatus unknownNCT04433481Not applicable
• Dabigatran for Mitral Stenosis Atrial FibrillationActive, not recruitingNCT04045093Phase 4
• DOAC Versus VKA After Cardiac SurgeryWithdrawnNCT04002011Phase 2
• PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial FibrillationCompletedNCT03996772Phase 3
• Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study)Status unknownNCT03975062Phase 4
• Treating Acute Pancreatitis With Dabigatran, a Pilot StudyTerminatedNCT03807856Phase 1
• RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKDStatus unknownNCT03789695Phase 4
• A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age.WithdrawnNCT03752294Phase 1
• Study of PF-04965842 Effect on Dabigatran Pharmacokinetics in Healthy ParticipantsCompletedNCT03742336Phase 1
• Dabigatran Versus Warfarin With NVAF Who Undergo PCIStatus unknownNCT03536611Phase 4
• A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous ThromboembolismStatus unknownNCT03240120Phase 3
• The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous ThrombosisStatus unknownNCT03217448Phase 3
• Dabigatran in Patients With Atrial Fibrillation and Mitral Biological ProsthesesStatus unknownNCT03183843Phase 4
• Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral AnticoagulantsCompletedNCT03181386Phase 3
• Start or STop Anticoagulants Randomised Trial (SoSTART)CompletedNCT03153150Phase 3
• Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular DiseaseCompletedNCT02982850Phase 4
• Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic TherapyStatus unknownNCT02979561Phase 4
• A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy ParticipantsCompletedNCT02945020Phase 1
• ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)CompletedNCT02935855Phase 4
• The Coagulation Cascade in Idiopathic Pulmonary FibrosisStatus unknownNCT02885961Not applicable
• Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)TerminatedNCT02872649Phase 2
• COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome TrialsWithdrawnNCT02723981Phase 4
• Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial FibrillationStatus unknownNCT02666157Phase 4
• Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.TerminatedNCT02596555Phase 4
• Left Atrial Thrombus Reduction - Effect of Dabigatran Versus PhenprocoumonStatus unknownNCT02591225Phase 4
• Pleotropic Effect of New Oral AnticoagulantsStatus unknownNCT02544932Phase 3
• Effect of Inhibitors of the Proton Pump on Intestinal TransportersCompletedNCT02524210Phase 1
• Safety & Suitability of Dabigatran to Inhibit Thrombin in SclerodermaCompletedNCT02426229Phase 1
• Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery DiseaseCompletedNCT02389582Phase 4
• Dabigatran in an Interaction Probe Drug CocktailCompletedNCT02361619Phase 1
• Anti-inflammatory Effects of Rivaroxaban Versus DabigatranStatus unknownNCT02331602Phase 4

← Dabigatran overview